Enhancing hypertension detection and control through a hypertension certification program for pharmacists: A cluster randomized trial (The RxPATH Study

Group I started in the control sional aspects of the consultation, (2) the depth of the patient’s phase enrolling control patients while they were completing relationship with the pharmacist and (3) the perceived length the HC-PCP. [...] However, pharmacists were Due to the global COVID-19 pandemic, the start of the study not informed about the cluster randomization design of the was postponed. [...] For analysis, it was determined that the date at which they switched from the control to intervention period was the date they finished the fourth module quiz of the HC-PCP and began the case evaluation of the HC-PCP in which they were required to demonstrate examples of provid- ing the intervention for feedback from hypertension experts to pass and complete the program. [...] Further investigations of the HC-PCP and its impact were asked to complete the CSQ after their final visit, hav- on patients’ systolic BP may include the evaluation of the clini- ing received the intervention. [...] RTT and YA were involved in the conceptualization and funding of the study and participated in the study design.